Analyst Ratings for Diplomat Pharmacy Inc. (DPLO)

Updated: 2017-07-27

Shares of Diplomat Pharmacy Inc. (NYSE:DPLO) have received a consensus rating of Hold from Wall Street analysts. DPLO had previously received a consensus rating of Hold a month ago.

A buy rating was issued by 3 analysts, 1 gave an overweight rating, 7 issued a hold rating, 0 gave an underweight rating, and 1 issued a sell rating. Compared to three months ago, there has been an increase of 1 in the number of analysts with a positive outlook on the stock. Meanwhile, the number of analysts pessimistic about the company has increased by 0.

Several price targets were given for DPLO by the analysts covering the stock. The most optimistic analyst gave a price target of 20, implying potential capital gains of 28.87 percent. The most pessimistic price target was 11, which equates to a potential downside of -29.12 percent. One must be careful with overanalyzing price targets and ratings due to possible conflicts of interest among the analysts releasing them.

Over the past month, analysts have revised their estimates for this quarter's earnings, with a net average change of 3.33 percent. The average change in earnings estimates over the last 90 days is -3.12 percent. Over the past 30 days, FY earnings estimates have also changed downwards by -1.52 percent. Expanding the time horizon to 3 months, the average change in fiscal year estimates becomes 1.56 percent.

Investors like to see analysts making revisions in the same direction, as that raises confidence in the revisions. 1 analysts made positive revisions to their quarterly estimates over the past month, while 0 analysts revised their estimates downwards. Also over the last month, 1 analysts increased their estimates for the FY earnings, while 2 analysts decreased their estimates.

Analysts estimate earnings of DPLO to grow at a rate of 155.68 percent. People on Wall Street often look at a company's PEG ratio. Investors like to see smaller values for the PEG ratio, as that can indicate whether the high price level of a stock is warranted by high growth. PEG ratios below 1 are often considered desirable, although it is frequently more appropriate to compare PEG ratios to the company's peers. The PEG ratio of DPLO is 0.4.

In the last 52-weeks, DPLO has achieved a high of 38.94 and a low of 12.25. The current market price is above the trailing year's low by 26.69 percent, and below the high by 60.14 percent. DPLO has a P/E ratio of 62.08. Investors typically compare the P/E ratio to a company's peers in the industry. The DPLO value stock report compares DPLO to some of its peers using value stock charts. The market cap of DPLO is $1.06 billion. DPLO's next earnings release will be on 0000-00-00, which is days away.